A109 PREGNANCY OUTCOMES IN WOMEN EXPOSED TO USTEKINUMAB IN THE CROHN’S DISEASE CLINICAL DEVELOPMENT PROGRAM

BACKGROUND: Ustekinumab (UST) has been approved for moderate to severe Crohn’s Disease (CD) in adult patients (pts). While no adverse developmental outcomes (pre-& postnatal) were observed in animal studies of UST, limited data exist, including previously reported outcomes in psoriasis (PsO) pts...

詳細記述

保存先:
書誌詳細
出版年:J Can Assoc Gastroenterol
主要な著者: Scherl, E, Jacobstein, D, Murphy, C, Ott, E, Gasink, C, Baumgart, D C, Abraham, B
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2018
主題:
Paper Sessions
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6508401/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.109
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料